Advanced company searchLink opens in new window

AUTIFONY THERAPEUTICS LIMITED

Company number 07543962

Filter by category

Filter by category


Confirmation statement filters

Company Results (links open in a new window)
Date (document was filed at Companies House) Type Description (of the document filed at Companies House) View / Download (PDF file, link opens in new window)
29 Jul 2024 SH01 Statement of capital following an allotment of shares on 29 July 2024
  • GBP 28,681.375
29 Jul 2024 SH01 Statement of capital following an allotment of shares on 29 July 2024
  • GBP 28,636.375
02 Jul 2024 AA Group of companies' accounts made up to 30 September 2023
28 Jun 2024 MA Memorandum and Articles of Association
28 Jun 2024 RESOLUTIONS Resolutions
  • RES10 ‐ Resolution of allotment of securities
  • RES13 ‐ Re-issue of equity securities 05/06/2024
  • RES11 ‐ Resolution of removal of pre-emption rights
  • RES01 ‐ Resolution of adoption of Articles of Association
05 Mar 2024 CS01 Confirmation statement made on 25 February 2024 with updates
27 Feb 2024 SH01 Statement of capital following an allotment of shares on 26 February 2024
  • GBP 27,436.375
08 Feb 2024 TM01 Termination of appointment of Atul Chandra Pande as a director on 31 January 2024
23 Nov 2023 SH01 Statement of capital following an allotment of shares on 23 November 2023
  • GBP 27,111.375
12 Oct 2023 SH01 Statement of capital following an allotment of shares on 12 October 2023
  • GBP 27,086.375
17 Jun 2023 AA Group of companies' accounts made up to 30 September 2022
23 Mar 2023 CS01 Confirmation statement made on 25 February 2023 with updates
30 Jan 2023 SH01 Statement of capital following an allotment of shares on 30 January 2023
  • GBP 27,056.375
13 Jan 2023 PSC07 Cessation of Pfizer Inc as a person with significant control on 12 January 2023
28 Jun 2022 SH01 Statement of capital following an allotment of shares on 9 June 2022
  • GBP 26,990.375
20 Jun 2022 AA Group of companies' accounts made up to 30 September 2021
04 Mar 2022 CS01 Confirmation statement made on 25 February 2022 with updates
22 Feb 2022 MR04 Satisfaction of charge 1 in full
08 Nov 2021 PSC02 Notification of Pfizer Inc as a person with significant control on 1 November 2021
08 Nov 2021 PSC07 Cessation of Svls Life Sciences Fund V Lp as a person with significant control on 1 November 2021
08 Nov 2021 PSC05 Change of details for Touchstone Innovations Businesses Llp as a person with significant control on 1 November 2021
23 Jul 2021 SH01 Statement of capital following an allotment of shares on 8 June 2021
  • GBP 26,950.375
10 Jun 2021 AA Group of companies' accounts made up to 30 September 2020
06 May 2021 CS01 Confirmation statement made on 25 February 2021 with updates
18 Jan 2021 SH01 Statement of capital following an allotment of shares on 18 January 2021
  • GBP 26,145.375